hanna it is not inconceivable that RXI won't be trading in the double digits before too long. Won't it be fine if we have to make those decisions in the event?....................GLTA
Cauwenbergh will deliver. He has a long history of delivering. My money is on him.......GLTA
wide, you don't appear very bright imo. I suggest that you read sabaid's post three or four times. More if you have to......................GL
No sooner, no later. No company hype a very positive sign to me. They know what they have and will advance their science in all avenues possible. It just takes time, no way around it. Not many small bio's with the experience, talent, and the potential as RXI, IMHO. GLA
hanna one must do their dd as you have done. Keeping an open eye is key. Your assessment of the company is on target, although I feel that one should have the patience for this type investment and not be overly concerned daily. The message board has no bearing on the course RXI will take.. My point, let's keep each other posted here but discount a MB for what it is, mostly useless outside of a few................GL
A stock basher spreads rumors about a security to push the trading price down. Bashers may act on their own account or represent third parties, and may engage in a coordinated attack with a group of people to make their claims seem more legitimate. Individuals suggesting that a company might be headed for trouble might not attract attention, but multiple rumors appearing to originate from different sources are apt to be taken more seriously. Environments like Internet message boards can be particularly fertile ground for stock bashers.
This activity may be illegal under laws governing activities on the stock market, depending on regulations. They could be considered a form of securities fraud if bashers operate with the goal to drive prices down to damage a company. Among the most widely known and notorious stock bashers is a certain avi.morax, known to post continually on mostly low priced biotech stocks.
Agree, but don't waste your breath hanna. In the scheme of the company, a message board means very little. It has no bearing nor any sway of a stock whatsoever.
It is to be viewed as a forum where one just might pick up occasional info of value. Discount a stock message board for what is is worth. btw, I,m liking this company more by the week.............GL
that was the same year I got into bed with Minny Mouse. Feb 06 2:00 EST. What a coincidence....
From 2002 to 2008, Dr. Cauwenbergh served as Chief Executive Officer and Chairman of Barrier Therapeutics, Inc., a publicly-traded biopharmaceutical company that he founded in 2001. Barrier, which focused on dermatology drug development, was acquired by Stiefel Laboratories, Inc. in 2008. Prior to founding Barrier, Dr. Cauwenbergh held a number of ascending senior management positions at Johnson & Johnson, where he was employed for 23 years.
There is info with more detail, when I find it I'll send it.................
A simple reminder;
A stock basher spreads rumors about a security to push the trading price down. Bashers may act on their own account or represent third parties, and may engage in a coordinated attack with a group of people to make their claims seem more legitimate. Individuals suggesting that a company might be headed for trouble might not attract attention, but multiple rumors appearing to originate from different sources are apt to be taken more seriously. Environments like Internet message boards can be particularly fertile ground for stock bashers. A certain basher who goes by the name avi-morax posts his negative comments but can never back them up with meaningful or current information.
Watch out for this guy..........................
moron Geert Cauwenberg headed J&J's wordwide skincare operations for 20 years. Oh, and did you know he has since sold two companies that he led in the $B range? 12 year old news doesn't cut it moron. No wonder why everybody hates you.......................
Good comments hanna. Per financial matters, Cauwenbergh is a very capable CFO. btw, "a blockbuster" may just be in the works....................GL
Must keep in mind, of the three trials, success in any advances the drug. Geert is very shrewd in covering the bases imo. I,m at a loss as to which may be more important to the company, rx-109 or sdrx?
It is likely that any potential partner or license for the self delivery tech is waiting on the very validation. Who wouldn't?
I do know that if the science works as expected, We have the talent to maximize its potential. It is why I remain long............just a thought this afternoon..............GL
ALNY, put together by VC's. Third Rock being one of them. They had the advantage of big money, started up on profits of huge successes. Money follows success. ALNY a perfect example.
As for the comparison with RXI, RXI did not have the advantage of a history of success. A spin off that a shot at an unmet market in scarring, a therapeutic that seems to garner little interest. Nonetheless, I think this company is so far under the radar still. It's clinical success will give them exposure.
I have more thoughts, will post later...........Good luck All.
Does that tell any of you anything?..................GL